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Abstract
Autoinducer-2 (AI-2) mediated quorum sensing has been associated with the expression of virulence factors
in a number of pathogenic organisms and has been demonstrated to play a role in motility and cytolethal
distending toxin (cdt) production in Campylobacter jejuni. We have initiated the work to determine the
molecular basis of AI-2 synthesis and the biological functions of quorum sensing in C. jejuni. In this work, two
naturally occurring variants of C. jejuni 81116 were identified, one producing high-levels of AI-2 while the
other is defective in AI-2 synthesis. Sequence analysis revealed a G92D mutation in the luxS gene of the
defective variant. Complementation of the AI-2− variant with a plasmid encoded copy of the wild-typeluxS
gene or reversion of the G92D mutation by site-directed mutagenesis fully restored AI-2 production by the
variant. These results indicate that the G92D mutation alone is responsible for the loss of AI-2 activity in C.
jejuni. Kinetic analyses showed that the G92D LuxS has a ∼100-fold reduced catalytic activity relative to the
wild-type enzyme. Findings from this study identify a previously undescribed amino acid that is essential for
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the functions of AI-2 mediated quorum sensing in Campylobacter.
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Introduction
The role of quorum sensing in the adaptation and colonization
of bacterial pathogens has been of increasing interest over the last
decade. A growing body of evidence suggests that the direct
sensing of threshold levels of various quorum sensing compounds
is associated with changes in gene regulation resulting in altered
phenotypic expression of virulence factors. [1,2,3]. Examples of
such changes include regulation of adherence, motility, toxin
production and expression of type three secretion systems in a
variety of bacterial species. [4,5,6,7,8,9,10]. While the quorum
sensing mechanisms of Gram-positive bacteria are often associated
with the production and sensing of modified peptide signals, the
autoinducers of Gram-negative bacteria are more commonly acyl-
homoserine lactones[11,12]. Another form of quorum-sensing,
mediated by autoinducer-2, has been described as a highly
conserved inter-species mechanism of communication with genetic
conservation over a large number of both Gram-positive and
Gram-negative bacteria [12,13]. Production of AI-2 requires the
activity of a conserved LuxS protein, a S-ribosylhomocysteinase
that converts S-ribosylhomocysteine into homocysteine and 4,5-
dihydroxy-2,3-pentanedione (DPD) [14]. Under physiological
conditions, DPD spontaneously cyclizes to form a mixture of
several furanones which are collectively referred to as AI-2.
LuxS is a Fe2+metalloenzyme whose catalytic mechanism has been
extensively studied and well defined [14,15,16,17]. Two universally
conserved residues, Cys-84 and Glu-57 (amino acid numbering in E.
coli LuxS), have been shown to act as critical general acids/bases during
catalysis. In addition, several other active-site residues including Ser-6,
His-11 and Arg-39 are also important for full activity [14,17].
Campylobacter jejuni is a leading cause of foodborne bacterial
enteritis in the United States and many developed countries
[18,19,20]. Foodborne cases are most commonly associated with
the consumption of contaminated poultry products, milk or
drinking water [20]. Although the majority of cases result in
relatively mild self-resolving enteritis, severe infections require
treatment with antimicrobial compounds [21]. The flouroquino-
lone and macrolide classes of antimicrobials represent the most
commonly prescribed drugs used in severe human infections [22].
An increasing prevalence of antimicrobial resistant Campylobacter
isolates has resulted in a renewed effort to identify novel means of
control for this bacterial pathogen [22,23]. Results in other bacterial
species have suggested that the quorum sensing mechanisms may
represent a viable target for bacterial control [24,25,26,27,28,29],
however there are significant knowledge gaps in our understanding
of the quorum sensing mechanisms of C. jejuni.
In order to determine the viability of utilizing quorum sensing
mechanisms of Campylobacter as a therapeutic target we must first
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expand our understanding of both the molecular mechanisms
responsible for autoinducer production and their role in virulence.
Currently, evidence suggests that AI-2 mediated quorum sensing
may play a role in motility, in vitro bacterial agglutination, and the
production of cytolethal distending toxin by Campylobacter jejuni
[5,7,8,30]. This paper details the identification and description of
a naturally occurring LuxS mutant strain of Campylobacter jejuni and
provides new insights into the molecular mechanisms of LuxS
production and function in this organism.
Materials and Methods
Strains and Culture Media/Conditions
The parent strain used in this study was Campylobacter jejuni 81116
(NCTC11828), an isolate obtained from a human enteritis outbreak
in a boarding school located in the United Kingdom in 1983 [31].
The 81116AI2- variant is the AI-2 deficient clone of this strain
maintained and passaged in the author’s laboratory. The
81116AI2+ strain is the AI-2 competent clone obtained from an
independent laboratory. Other strains utilized in this study are
detailed in Table 1. All strains are maintained in 20% glycerol stock
at 280uC. C. jejuni strains were passaged on Mueller-Hinton agar
(without blood) or broth in a microaerophilic environment
generated by the use of compressed gas (5% O2, 10% CO2, 85%
N2). Routine cultures were incubated at 42uC. Campylobacter jejuni
strains with antimicrobial resistance markers were grown on
kanamycin (30 mg/ml) or chloramphenicol (4 mg/ml) when appro-
priate. All Escherchia coli strains used for genetic manipulation were
grown in Luria-Bertani (LB) broth or agar and incubated in a
normal atmosphere at 37uC.When appropriate kanamycin (40 mg/
ml), chloramphenicol (20 mg/ml), or ampicillin (30 mg/ml) was
added to the culture media. Vibrio harveyi strains were grown in
autoinducer broth (AB Broth) as described previously [32].
Insertional Mutation of the LuxS gene of C. jejuni. An
isogenic luxS mutant of C. jejuni NCTC 11168 was constructed by
insertional mutagenesis. Primers luxSF4 and luxSR4 (Table 2)
were used to amplify a 445 bp luxS fragment with a unique
HindIII site in the middle region of the fragment. The PCR
fragment was cloned into the pGEM-T Easy vector (Promega),
resulting in the construction of pLUXS. Primers kanF and kanR
(Table 2) were used to amplify the kan gene encoding kanamycin
resistance from KAN-2 Transposon using the PfuTurbo DNA
polymerase (Stratagene). After the HindIII digestion, the kan PCR
product was ligated to the HindIII digested pLUXS to obtain
plasmid construct pLUXSK, which was then transformed into E.
coli JM109. pLUXSK, which serve as a suicide vector in
Campylobacter, was introduced into C. jejuni NCTC 11168 using an
electroporator (Gene Pulser Xcell System; Bio-Rad Laboratories).
Transformants were selected on MH agar containing kanamycin
50 mg/ml. PCR analysis of the luxS mutant confirmed that the kan
gene was inserted into the luxS gene in the same orientation as the
luxS gene. Natural transformation was used to move this gene
insertion into additional C. jejuni strains as previously described [33].
Vibrio harveyi autoinducer-2 bioassay. Autoinducer-2 (AI-
2) levels of cell-free spent culture media were measured using the
Vibrio harveyi bioluminescence assay as previously described [34].
Briefly, the cell-free spent media was prepared by centrifugation of
the sample at 10,0006g for 5 minutes followed by filter sterilization
through a 0.25 mm syringe filter. Cell-free supernatant was
immediately frozen at 280uC until being subjected to AI-2
measurement. A 10 mL aliquot of each sample was used in the
Table 2. Primers used in this study.
Primers Sequence
Target
Gene
Cj1198F1 GTTGGATCCCCATTATTAGACAGCTTTAAAGT luxS
Cj1198R3 TAATCTGCAGTTTAAGCATTCTCGAGTTTT luxS
LuxSF4 ACCTAAGGGTGATGATATTA luxS
LuxSR4 GCTTAATCATTTAAAAAATAA luxS
KanF TTAAGCTTGCATCGATGAATTGTGTCTCAAAA KnR
KanR TTAAGCTTGGTGGACCAGTTGGTGATTT KnR
luxSF7 TAGTCTAGATCATTTAAAACAGGCAAAGC luxS
luxSR9 GTCCTGCAGCACATCTCGCACATCAGTT luxS
luxS256G P-GTTGTCGCACGGGTTTTTATATGAG luxS
doi:10.1371/journal.pone.0015876.t002
Table 1. Bacterial strains and plasmids used in this study.
Bacterial Strains Description Reference
81116AI2- A variant of C. jejuni 81116 negative with AI-2 This study
LuxS- 81116AI2- LuxS insertional mutant This Study
AI2-(pLuxS) 81116AI2- with plasmid encoded 11168 LuxS This Study
AI2-(p256G) 81116AI2- with plasmid encoded site directed revertant of
81116AI2- LuxS ORF
This Study
81116AI2+ C. jejuni 81116 positive with AI-2 [31]
11168 C. jejuni NCTC 11168 [48]
11168DluxS 11168 mutant with kanR inserted into luxS This Study
BB170 AI-2 reporter strain; luxN::Tn5 [49]
BB152 AI-1-, AI-2+; luxM::Tn5 [32]
Plasmids
pRY111 E. coli-Campylobacter shuttle plasmid, KanR [35]
puc256G puc19 plasmid containing site directed revertant This Study
pRY256G pRY111 backbone with site directed revertant LuxS This Study
doi:10.1371/journal.pone.0015876.t001
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bioluminescence assay and the relative light units of
bioluminescence were measured using a Turner Biosystems
Reporter Luminometer. Cell free supernatant of Vibrio harveyi
strain BB152 was used as a positive control and LB and MH broth
media were both used as negative controls. All measurements were
reported at the 3 hour incubation period when the difference
between negative controls and positive controls reached maximal
levels. Results reported are the average of three independent
assays.
Complementation of LuxS deficient variant in trans
Complementation of AI-2 phenotype of the Cj81116AI2- variant
was performed using a plasmid-carried gene. Briefly, the luxS open
reading frame and 500 bp of the upstream region of non-coding
sequence of Cj81116AI2+ were cloned into the pRY111 vector [35].
The vector was conjugated into 81116AI2- as described below and
selected using MH media plus chloramphenicol (4 mg/mL).
Site-directed mutagenesis. Site-directed mutagenesis of the
single nucleotide substitution found in C. jejuni strain 81116AI2- was
performed in order to revert the substituted aspartic acid residue to
the wild-type glycine found in the AI-2 competent 81116AI2+
strain. Site-directed mutagenesis was performed using the
Transformer Site-Directed Mutagenesis Kit (Clontech) according
to the manufacturer’s recommendations. Briefly, the full luxS ORF
and approximately 500 bp of the upstream non-coding promoter
region of strain 81116AI2- was amplified using the luxSF7
(including a Pst I site) and luxSR9 (including a Xba I site) primers.
The PCR products and the puc19 plasmid were each individually
subjected to restriction enzyme digestion with Pst I and Xba I.
Following digestion the samples were purified using a Qiagen PCR
Clean-Up column and ligated using T4 ligase (Promega). The
plasmid was transformed into chemically competent DH5a cells
(Invitrogen) and selected using LB media containing 100 mg/ml
ampicillin, X-Gal and IPTG. As single clone was selected and DNA
sequencing confirmed the plasmid contained the appropriate insert.
Site-directed mutagenesis was performed using the 59-
phosphorylated control selection primer provided in the kit and a
59-phosphorylated mutagenesis primer designed in this study and
called luxS256G. The mutagenesis primer was designed to replace
the adenine at nucleotide 256 of the C. jejuni luxS ORF with a
guanine. Selection of desired mutants was performed as described
by the manufacturer using Nde I restriction enzyme digestion. DNA
sequencing was utilized to verify the isolation of puc256G, the
puc19 plasmid containing the 81116AI2- luxSORF with the A256G
nucleotide mutation. PCR amplification of the mutated luxS ORF
and promoter region in the puc256G plasmid was performed using
the luxSF7 and luxSR9 primers used above, digested with Pst I and
Xba I and ligated into a similarly digested pRY111 C. jejuni shuttle
vector to yield the pRY256G plasmid. To transfer the pRY256G
shuttle vector into the C. jejuni 81116AI2- strain, conjugation was
performed as previously described [36].
Production of histidine-tagged recombinant LuxS
protein. Six-histidine-tagged recombinant proteins were produced
in E. coli JM109. The luxSORF of both C jejuni 81116AI2- and C. jejuni
81116AI2+ were cloned in frame into the multicloning site of
the pQE30 expression vector (Qiagen). The ORF was amplified
by PCR using primers Cj1198F1 (including a Bam HI site)
and Cj1198R3 (including a Pst I site), digested with Bam HI
and Pst I, and ligated into a BamHI/PstI digested pQE30 plasmid.
The authenticity of the plasmid was confirmed by sequencing the
entire luxS gene. Recombinant proteins were produced following the
manufacturer’s recommendations for the pQE30 expression system.
The eluted fraction was diluted to a total volume of 2.5 mL with
10 mM phosphate buffer, desalted using a PD-10 desalting column
(Amersham) and concentrated using a Millipore centrifugal
concentration column with a 10,000 MW size exclusion (Millipore).
The concentration of the recombinant protein was determined using a
standard BCA protein assay kit (Pierce). The protein was diluted to
1 mg/mL and flash frozen at 280uC in small aliquots. Cobalt-
substituted LuxS was prepared as previously described [16]. Briefly,
cells were grown in minimal media containing Co2+. At the time of
induction, cobalt chloride was added to a final concentration of
10 mM, along with IPTG. The cells (from x l) were collected by
centrifugation and resuspended in 4 ml of a lysis buffer (20 mM Tris,
pH 8.0, 0.5 M NaCl, 5 mM imidazole, 1% Triton X-100, 0.5%
protamine sulfate and 70 mg/mL chicken egg lysozyme). The sample
was incubated at 4uC for 20 min and centrifuged. The supernatant
was mixed with 1.5 mL of Talon Cobalt Purification resin (Clontech)
and the mixture was transferred into a 5-mL column (Qiagen). The
column was washed with 2 column volumes of washing buffer (20 mM
Tris (pH 8.0), 0.5 M NaCl, and 5 mM imidazole) and the bound
protein was eluted with 5 mL of elution buffer (20 mM Tris (pH 8.0),
0.5 M NaCl, and 60 mM imidazole). The eluted fraction was
concentrated using a Centricon 10 (10,000 MW cutoff) to about half
their volume and the protein was quantitated using a BCA Protein
Assay Kit (Pierce). Glycerol was added to a final concentration of 20%
and the proteins were flash frozen at 280uC.
Circular dichroism of recombinant proteins. Circular
dichroism analysis of the recombinant LuxS proteins from
81116AI2- and 81116AI2+ were performed to compare the
secondary structure of the proteins. The proteins were tested in a
10 mM phosphate buffer using a Jasco J-710 Spectropolarimeter.
Measurements were recorded at a 0.2 nm resolution from 190 nm
to 260 nm with a sensitivity of 20 mdeg. The assay was performed
at room temperature.
In vitro synthesis of S-ribosylhomocysteine. S-
ribosylhomocysteine was synthesized as previously described with
slight modification [37]. A 10 mg/mL solution of S-
adenosylhomocysteine (Sigma) was dissolved in 0.1 M HCl,
boiled for 90 min and neutralized with an equal volume of
0.1 M NaOH [38]. ESI positive and negative mode mass
spectroscopy was used to verify the disappearance of the SAH
peak at 385 m/z and the presence of the expected 266 m/z SRH
peak. This method has previously been demonstrated to provide a
relatively pure SRH product [37]. Furthermore, incubation of the
synthesized product with recombinant LuxS wildtype enzyme
clearly demonstrated AI-2 synthesis while incubation of the
recombinant enzyme with the SAH failed to produce
measureable AI-2 or homocysteine.
In vitro AI-2 synthesis reaction. The ability of the
recombinant LuxS proteins to synthesize biologically active AI-2
was assessed essentially as previously described [37]. Briefly,
100 mL of recombinant protein (1 mg/mL) was added to 300 mL
of synthesized SRH (approximately 2.5 mg/ml) and the mixture
was incubated at 37uC for 1 hour. Following the incubation the
sample was applied to a Ultramax 5,000 MW cut-off centrifuge
filter to remove the protein. To assess for AI-2 activity 10 mL of the
filtrate was used in the Vibrio harveyi AI-2 bioassay as described
above. When the sample was to be used for quantification of
homocysteine formation the incubation was modified slightly. For
these experiments 50 mL of recombinant enzyme (1 mg/mL) was
added to 250 mL of SRH (,2.5 mg/mL) and the incubation time
was shortened to 15 minutes due to the instability of the
homocysteine at 37uC [37].
Measurement of homocysteine formation by recombinant
LuxS proteins. In order to measure the homocysteine formation
by the recombinant LuxS proteins a standard Ellman reaction was
utilized to measure the formation of free thiol groups as previously
Key Amino Acid of LuxS in C. jejuni
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described [37]. Briefly, an equal volume of the DTNB (Sigma)
working stock (5 mM) was added to the filtrate obtained following
the synthesis reaction. The absorbance at 412 nm was used to
quantitate the homocysteine formed by the reaction.
LuxS Activity Assay. LuxS reactions were performed in a
buffer containing 50 mM HEPES (pH 7.5), 150 mM NaCl,
150 mM 5,59-dithio-bis-(2-nitrobenzoic acid) (DTNB) and various
concentrations of SRH (0–80 mM). The reactions were initiated by
the addition of LuxS (final concentration 1.3 mM for wild-type and
8.4 mM for G92D mutant) and monitored continuously at
412 nm (e=14150 M21 cm21) in a Perkin-Elmer l25 UV-VIS
spectrophotometer at room temperature (23uC). The initial rates
recorded from the early regions of the progress curves were fitted
against the Michaelis-Menten equation V = kcat [E]0 [S]/(KM +
[S]) using KaleidaGraph 3.5 to determine the kinetic constants.
Quantitation of AI-2 in Culture Fluids. Cell free supernatants
of both 81116AI2- and 81116AI2+ cells were collected at specific
time points during a 24-hour growth period. The cell density was
determined by measuring the OD600. The cultures were centrifuged
and filtered through a 0.25 mM Acrodisc filter to remove bacterial
cells. The resulting supernatant (30260 mL) was added to 1.0 mM
LuxP137Dap in 50 mMHepes (pH 7.0) and 150 mMNaCl, and the
fluorescence spectra were recorded before and after incubation with
1.6 mM borate for 5 min at room temperature (total volume 1 ml)
[39]. The AI-2 concentration was calculated from the fluorescence
increase at 494 nm using known concentrations of DPD as
calibration standards.
Results
Identification of a naturally occurring AI-2 deficient
variant of C. jejuni
Several C. jejuni isolates commonly used for laboratory research
were screened for their ability to synthesize AI-2. Surprisingly, the
81116 strain maintained in our laboratory (named 81116AI2- in this
study) was found to be deficient in AI-2 synthesis when assessed by
the V. harvyei AI-2 bioassay and compared to the bioluminescence
obtained with other C. jejuni isolates and the negative controls. Unlike
the positive control strains, 81116AI2- did not produce AI-2 during
any stage of the growth phase. (Figure 1A) Since the V. harveyi
bioassay is not quantitative, we next determined the concentration of
AI-2 in the culture fluids of 81116AI2+ and 81116AI2- cells using a
LuxP-based fluorescent sensor recently developed in one of our
laboratories [39]. For this experiment, 81116AI2+ and 81116AI2-
were grown in MH media under identical conditions. A sample of
the culture media was collected at specified time points and the cell
free supernatant was collected and mixed with the LuxP137Dap
sensor protein (in the presence of 1.6 mM borate), and the
fluorescence yield at 494 nm was measured. Comparison with AI-
2 standards confirmed that the 81116AI2+ cells produced significant
levels of AI-2 starting at,9 h and the AI-2 level peaked at 42 mMat
,22 h (Figure 2). In contrast, the 81116AI2- cells produced no
detectable amounts of AI-2 (detection limit ,1 mM) at any stage.
Complementation of the strain with a plasmid encoded copy of the
luxS ORF from an AI-2 producing strain of C. jejuni (NCTC 11168)
resulted in the production of AI-2 at levels comparable to positive
control strains (Figure 1A). Since strain 81116 was know to be
positive in previous studies by other laboratories [8], we obtained
another copy (named 81116AI2+ in this study) of strain 81116 from
an independent laboratory (Michael Konkel, Washington State
University) to verify the AI-2 deficient phenotype observed in strain
81116AI2-. It was found that the AI-2 level of 81116AI2+ as
measured by bioluminescence assay was essentially identical to those
produced by NCTC11168 and the VhBB152 positive control strain
(Figure 1B). These findings suggest that 81116AI2- is an AI-2
deficient variant of strain 81116 and may harbor a genetic change
that is responsible for the loss of AI-2 production.
A single point mutation in LuxS is responsible for the loss
of AI-2
To determine the genetic basis for the phenotypic difference
between 81116AI2- and 81116AI2+, we compared the sequences
of the luxS gene in the two variants. No difference was observed in
the promoter region of the luxS gene, however, a single adenosine
to guanosine mutation was observed at position 256 of the luxS
gene in 81116AI2-. The mutation results in the substitution of an
aspartic acid for glycine-92 in the LuxS protein. Sequence
alignment of 14 LuxS proteins from a wide range of bacterial
species revealed that the glycine residue is conserved across all
species (Figure 3). To determine whether the G92D mutation is
responsible for the loss of AI-2 production, we mutated the Asp-92
back to a glycine by site-directed mutagenesis. Introduction of a
plasmid copy of the revertant luxS gene into the 81116AI2- strain
restored its ability to produce AI-2 to the same level as the
81116AI2+ strain (Figure 1B). Thus, the deficiency in AI-2
production is caused by the G92D mutation.
The G92D mutant LuxS protein is catalytically deficient
zTo determine whether the G92D mutant LuxS is catalytically
deficient, we overexpressed both the wild-type and mutant LuxS
proteins in E. coli with an N-terminal six-histidine tag and purified
the recombinant proteins to near homogeneity by metal affinity
chromatography (Figure 4A). The circular dichroism spectra of the
two proteins are identical, suggesting that the mutation does not
significantly alter the secondary structure of the protein (Figure 5).
Kinetic analysis showed that the wild-type LuxS enzyme from
81116AI2+ had a kcat value of 0.009 s21, a KM value of 28 mM,
and a kcat/KM of 332 M
21 s21. In contrast, the activity of the
81116AI2- (G92D) LuxS enzyme was to low to allow for accurate
measurement of its kcat and KM values. Its kcat/KM value was
estimated to be,3.5 M21 s21, which is a 100-fold lower than that
of the wild-type enzyme. Therefore, while the G92D mutant
retains residual catalytic activity in vitro (figure 6), this 100-fold
reduction in activity results in a phenotypic loss of AI-2 production
in vivo.
Evaluation of SRH levels in the cell free supernatant of
cultures
Given that the LuxS protein of 81116AI2- is significantly
reduced in its ability to convert SRH to homocysteine and DPD,
we were interested in testing the SRH levels in the cell free media
of the various bacterial cultures. Previous work in other species has
demonstrated elevated SRH concentrations in the culture
supernatant of luxS mutant strains [40]. To test this we utilized
the in vitro AI-2 synthesis reaction described above with the
wildtype LuxS enzyme and the cell-free supernatant as the source
of substrate. In order to prevent any cross contamination of the
reaction with endogenously produced AI-2 the supernatant was
boiled for 5 minutes prior to the reaction then allowed to cool. The
data presented in figure 7 demonstrates that strains deficient in
their ability to produce AI-2 (81116AI2- and LuxS-) yield higher
RLU following in vitro synthesis when compared with AI-2
competent strains [81116AI2+ and AI2-(pD256G)]. Elevated
RLU units following the reaction are consistent with the presence
of an increased SRH concentration in the supernatant that is
reacted to produce AI-2 in the presence of the functional
recombinant LuxS enzyme.
Key Amino Acid of LuxS in C. jejuni
PLoS ONE | www.plosone.org 4 January 2011 | Volume 6 | Issue 1 | e15876
Discussion
C. jejuni 81116 is a commonly used laboratory strain that was
originally isolated from an outbreak of enteritis in a UK boarding
school in 1983 [31]. Since that time the strain has been widely
disseminated and maintained in laboratories around the world.
Despite the fact that this strain of C. jejuni is laboratory adapted
and has been subjected to repeated laboratory passage, evidence
suggest that the isolate has maintained an amazing level of genetic
stability over the last 20 years and that the AFLP pattern
determined in 2001 was identical to the co-isolates that had not
been passaged since 1983 [41]. Despite this considerable genome
stability, the data presented herein clearly demonstrates the
presence of a single nucleotide substitution in the open reading
frame of the luxS gene of 81116AI2- that results in a single amino
acid substitution and the loss of AI-2 phenotype. Identification of
such a mutation is not precluded by the genetic stability described
above since the sensitivity of the AFLP technique for the detection
of specific single amino acid changes is extremely low for the
portions of the genome not included in the restriction enzyme
recognition sites.
Interestingly, two previous studies regarding AI-2 competence of C.
jejuni have utilized isolates of 81116 and have demonstrated it to be AI-
2 positive [8,30]. To confirm our results we were able to obtain
genomic DNA of the 81116 isolate used by one of those laboratories as
well as a second 81116 isolate (81116AI2+) originating from a third
laboratory. Our results indicated that 81116AI2- is a variant of strain
81116 and harbors a single nucleotide substitution in luxS. This
mutation results in the substitution of an invariant glycine residue for a
much larger charged aspartate residue in LuxS. Based on crystallo-
graphic structures of several LuxS enzymes this residue is located at the
amino end of b-strand 4 [42]. In this position it is located within a
fraction of an angstrom from both the Cis-84 residue located 2 residues
upstream and the Arg-39 residue located on the adjacent b2-strand.
Both of these amino acids play important roles in the kinetics of the
enzymatic reaction and the stabilization of the enzymatic intermediates
[14,17].We speculate that the substitution with a larger charged amino
acid induces steric hindrance and electrostatic repulsion, which induces
conformational changes that result in decreased enzymatic kinetics.
Specifically, we speculate that the presence of the larger aspartate
residue results in either the b4 strand being displaced away from the
active site and pulling the Cis-84 residue out of its typical 3 dimensional
position or the displacement of the b2 strand towards the active site,
resulting in the Arg-39 residue displacement. In either case the relative
locations of these two residues would be disrupted, negatively
impacting enzymatic function. Given the lack of significant change
in circular dichroism spectra and the retention of some enzymatic
activity, this conformation change is assumed to be minor and may
only result in slight repositioning of some key active site residues.
To our knowledge, while at least one other naturally occurring
E. coli luxS mutant has been described [43], this isolate represents
the first description of a naturally occurring luxS mutant phenotype
Figure 2. AI-2 concentration curves for the two recombinant
proteins as a function of time and measured by FRET.
doi:10.1371/journal.pone.0015876.g002
Figure 1. Autoinducer-2 activity of strains used in study. A: Bioluminescence activity of 81116AI2- and AI2-(pLuxS) compared to the positive
control strains Campylobacter jejuni 11168 and Vibrio harveyi BB152. Each bar represents the average of three replicates with standard deviation. MH
both is shown as a negative control. BB152 – positive control B: AI-2 production of 81116 variants and conjugates. 81116AI2-, a laboratory strain with
the G92D mutation in LuxS (AI-2 negative), AI2-(p256G), a 81116 conjugate with a shuttle vector carrying a luxS gene in which the G92D mutation is
reverted; 81116AI2+, a 81116 variant with no mutation in luxS (AI-2 positive); and MH Broth, culture media serving as a negative control for AI-2
activity.
doi:10.1371/journal.pone.0015876.g001
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in C. jejuni. Previous studies have utilized site directed mutagenesis
to explore the amino acids involved in the active site and have
demonstrated significant reductions in the enzyme activity
associated with mutagenesis of these active site residues [14,17].
Data herein demonstrated that the single amino acid substitution
described in this isolate results in significant reductions in
enzymatic activity and ultimately the loss of AI-2 phenotype.
The circular dichroism spectra of the wildtype and mutant LuxS
were nearly identical (figure 5), suggesting that the secondary
structures of the proteins are largely conserved. While the ability of
circular dichroism to accurately predict secondary structure in silico
is limited, its ability to compare two similar proteins secondary
structure is much more robust [44].
Results of both the V. harveyi bioluminescence and FRET method
demonstrate the phenotypic loss of AI-2 in the 81116AI2- variant
when compared to 81116AI2+ and other C. jejuni strains (figures 1B
and 2). In contrast, the in vitro s-ribosylhomocysteinase enzymatic
kinetics demonstrated that relatively low levels of enzymatic activity
were still retained in the mutant LuxS. This retained but limited
enzymatic ability explains the detection of AI-2 production following in
vitro incubation of concentrated recombinant mutant enzyme with
excess of SRH (figures 4 and 6). Based on the enzyme kinetics of the
wildtype protein kcat/Km of 332/M/s and that of the mutant protein
at roughly 3.5/M/s we can estimate that the mutant protein has a
roughly 100-fold decrease in enzymatic activity. As a result, we believe
that the physiological concentrations of AI-2 produced during the in
vitro growth of 81116AI2-, using the media described, fall below the
limits of detection of our AI-2 assays (LOD for FRET ,1 uM)
resulting in a phenotypic loss of AI-2 activity while maintaining a
minimally-functional LuxS enzyme. Such levels would also fall well
below the 40 uM concentrations observed in the wildtype strain during
growth in the same media, however data regarding the concentration
of AI-2 necessary to result in signaling of C. jejuni is currently
unavailable and thus interpretation of the biological meaning of these
levels in hampered. The biological role of AI-2 competent strains of C.
jejuni is still unclear. Evidence suggest that luxS mutants have both
altered phenotypes and altered gene expression, however some of these
changes are clearly associated with altered metabolism and the role of
AI-2 mediated quorum sensing in this species remains uncertain
[45,46]. Furthermore, luxS mutants do demonstrate an altered ability
Figure 3. Sequence alignment of luxS genes including 81116. Highlighted amino acids are mutated in the 81116 (bottom row) compared to
the published 11168 sequence (2nd from bottom). ‘‘X’’ denotes the site of amino acid substitutions. Proteins used in the sequence alignment are as
follows (Protein Information Resource database ID numbers are shown in parentheses, with GenBank ID numbers given for ST, VH, and BH): HP,
Helicobacter pylori (C71973); DR, Deinococcus radiodurans (D75280); HI, Haemophilus influenzae (G64008); BB, Borrelia burgdorferi (BB0377); CP,
Clostridium perfringens (T43793); NM, Neisseria meningitides (G81963); ST, Salmonella typhimurium (AAF73475.1); VH, Vibrio harveyi (AAD17292.1); EC,
Escherichia coli (H65048); VC, Vibrio cholerae (F82309); BS, Bacillus subtillis (A69994); and BH, Bacillus halodurans (BAB07072.1).11168, Campylobacter
jejuni ATCC 11168; 81116AI2-, Campylobacter jejuni Strain 81116 from this study; 81116AI2+, Campylobacter jejuni Strain 81116 from this study.
doi:10.1371/journal.pone.0015876.g003
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to colonize animal models [47]. In the present study the mutant
exhibited a decreased motility consistent with previously published
findings of luxS mutants in this species [8,30].
The use of the FRET AI-2 assay in this manuscript provides, to
our knowledge, the first truly quantifiable data concerning the
physiological concentrations of AI-2 produced by C. jejuni grown in
Figure 5. Circular dichroism spectra of the rLuxS+ and rLuxS- recombinant proteins. The two protein spectra essentially overlay each
other identically throughout the spectra. The buffer is also shown as a control.
doi:10.1371/journal.pone.0015876.g005
Figure 4. The purity and activity of recombinant LuxS proteins synthesized in this paper. A: SDS-PAGE gel of recombinant LuxS proteins
from 81116AI2- and 81116AI2+ Lane 1: rLuxS- (expected MW=18.1 kD), the recombinant 81116AI2- 6HIS-tagged LuxS Protein, Lane 2: rLuxS+
(expected MW=18.1 kD), the 81116AI2+ 6HIS-tagged LuxS Protein, Molecular weight markers as shown. B: Enzymatic activity of recombinant LuxS
protein measured by Vibrio harveyi bioluminescence assay. SRH alone with no enzyme provides a negative control. BB152 is cell-free supernatent of V.
harveyi BB152 as a positive control.
doi:10.1371/journal.pone.0015876.g004
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in vitro environments. While the ability of the organism to truly
‘‘sense’’ the compound is still unproven, this quantification data
does provide much needed information concerning what range of
potential concentrations of chemically synthesized AI-2 should be
used to mimic natural production potentials. Based on our results
we believe that concentrations between 0 and 40 uM are
physiologically possible in logarithmic growth in MH media
routinely used for C. jejuni growth.
When comparing the results of the in vitro recombinant proteins
enzymatic reactions we observe that while no homocysteine can be
detected following incubation of SRH with the 1198AI2- enzyme
we do see measurable synthesis of AI-2 (figure 6). This provides
additional evidence of retention of low-level enzymatic activity of
the 81116AI2- strain but also provides clues into the biological
sensitivity of two of the assays utilized in detection of LuxS
enzymatic activity, homocysteine formation using the Ellman
reaction and AI-2 activity using the Vibrio harveyi assay. Given that
homocysteine will be produced in the in vitro reaction in a
stoichiometrically identical concentration to DPD, that then
becomes AI-2, the ability to detect low levels of AI-2 in the
absence of homocysteine suggest that the lower limit of detection
of the Ellman reaction, as performed in this manuscript, is greater
then that of the Vibrio bioluminescence assay.
As has been described for other organisms, the absence of a fully
functional luxS gene in C. jejuni does result in increased extracellular
concentrations of SRH (Fig. 7). The presence of increased SRH
concentrations in the naturally occurring mutant strain suggest that
despite measurable residual enzymatic activity of the mutant enzyme,
the metabolic ability of the organism to recycle SRH into the SAM
recycling pathway is hindered. Thus, in addition to the phenotypic loss
of AI-2 activity this strain has a phenotypic change in SAM recycling
which precludes the ability to attribute any of the phenotypic
characteristics observed directly to the loss of quorum sensing.
In conclusion, we have fully described the molecular basis for the
loss of AI-2 phenotype associated with a naturally occur luxSmutant
of C. jejuni. Given that the amino acid responsible for this loss of
function is highly conserved over a broad range of bacterial species,
we speculate that homologous mutations in other bacterial species
would also result in a loss of AI-2 phenotype. Additionally, the fact
that this amino acid mutation allows for the maintenance of
relatively normal secondary structure while diminishing enzymatic
activity to levels similar to that observed with luxS deletion mutants
suggest that this amino acid is critical for normal enzyme function.
Use of this isolate may be helpful in further defining the roles of AI-2
in quorum sensing in a wide variety of bacterial species since it does
provide a potential enzymatic intermediate between fully functional
and enzymatically incompetent.
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